All other professional, scientific and technical activities n.e.c.
NEXTA BIOTECH CONSULTING AS
Revenue 2025
NOK 3.0m
Operating profit
NOK 316,000
Equity
NOK 41,000
Incorporated
2024
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2025 | Trend |
|---|---|---|
| Total operating revenue | 3.0m | |
| Total operating costs | 2.7m | |
| Operating profit (EBIT) | 316k | |
| Net financial items | −1k | |
| Profit for the year | 245k |
Balance sheet
| Post | 2025 | Trend |
|---|---|---|
| Total assets | 950k | |
| of which current assets | 950k | |
| Equity | 41k | |
| Total liabilities | 909k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.